Skip to main content
Erschienen in: Pituitary 1/2018

06.12.2017

Bone histomorphometry in acromegaly patients with fragility vertebral fractures

verfasst von: L. Dalle Carbonare, V. Micheletti, E. Cosaro, M. T. Valenti, M. Mottes, G. Francia, M. V. Davì

Erschienen in: Pituitary | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Context

The high risk of vertebral fractures (VFs) in acromegaly patients despite normal bone mineral density (BMD) is well known. The reasons for this paradoxical finding of skeleton fragility are poorly understood due to the limited data on bone histomorphometry in acromegaly.

Objective

This study aimed to analyze histomorphometric parameters including bone microarchitecture in acromegaly patients with VFs and normal BMD compared to normal subjects, and also to evaluate the differences between active and controlled acromegaly patients.

Patients and methods

Forty-seven acromegaly patients (17 active, 30 controlled), median (range) age 57 years (30–88) were evaluated for bone turnover, morphometric VFs and BMD by dual-energy X-ray absorptiometry at lumbar spine and hip; 12 patients with VFs and normal BMD underwent iliac crest bone biopsy; 12 biopsies were taken at the autopsy in healthy sex and age—matched control subjects.

Results

The histomorphometric evaluation of acromegaly fractured patients was compared with that of normal controls and showed significantly reduced median (range) levels of bone volume/tissue volume (BV/TV: 15.37% (7.93–26.75) vs. 18.61% (11.75–27.31), p = 0.036), trabecular thickness (TbTh: 77.6 µm (61.7–88.3) vs. 82.7 µm (72.3–92.0) p = 0.045), with increased trabecular separation (TbSp: 536.4 µm (356.2–900.6) vs. 370.3 µm (377.1–546.3) p = 0.038) and increased cortical thickness (1268 μm (752–2521) vs. 1065 μm (851–1205) p = 0.025) and porosity (11.9% (10.2–13.3) vs. 4.8% (1.6–8.8) p = 0.0008). While active acromegaly patients showed histomophometric features of increased bone turnover, patients with controlled disease presented normal bone turnover with significantly lower osteoblastic activity, expressed as osteoblast number (p = 0.001), active osteoblasts and vigor (p = 0.014) in the presence of reduced osteocyte number (p = 0.008) compared to active disease.

Conclusions

The apparent paradox of bone fragility in acromegaly patients with a normal BMD can be explained by increased cortical thickness and porosity and reduced trabecular thickness with increased trabecular separation. These structural and microarchitectural abnormalities persist in the controlled phase of acromegaly despite bone turnover normalization. The main determinant of bone disease after hormonal control is severe osteoblastic dysfunction.
Literatur
1.
Zurück zum Zitat Alexander L, Appleton D, Hall R, Ross WM, Wilkinson R (1980) Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol 12:71–79CrossRef Alexander L, Appleton D, Hall R, Ross WM, Wilkinson R (1980) Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol 12:71–79CrossRef
2.
Zurück zum Zitat Carroll PV, Jenkins PJ (2016) Acromegaly, In: Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, De Groot, L.J., New M, Purnell J, Rebar R, Singer F, Vinik A (eds) Endotext South Dartmouth (MA): MDText.com, Inc; 2000 Carroll PV, Jenkins PJ (2016) Acromegaly, In: Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, De Groot, L.J., New M, Purnell J, Rebar R, Singer F, Vinik A (eds) Endotext South Dartmouth (MA): MDText.com, Inc; 2000
3.
Zurück zum Zitat Giustina A, Mazziotti G, Canalis E (2008) Growth hormon, insulin like growth factors and the skeleton. Endocr Rev 29:35–59CrossRef Giustina A, Mazziotti G, Canalis E (2008) Growth hormon, insulin like growth factors and the skeleton. Endocr Rev 29:35–59CrossRef
4.
Zurück zum Zitat Mazziotti G, Maffezzoni F, Giustina A: Vitamin D-binding protein: one more piece in the puzzle of acromegalic osteopathy? Endocrine 52(2):183–186 (2016)CrossRefPubMed Mazziotti G, Maffezzoni F, Giustina A: Vitamin D-binding protein: one more piece in the puzzle of acromegalic osteopathy? Endocrine 52(2):183–186 (2016)CrossRefPubMed
5.
Zurück zum Zitat Mazziotti G, Biagioli E, Maffezzoni F, Spinello M, Serra V, Maroldi R, Floriani I, Giustina A (2015) Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis. J Clin Endocrinol Metab 100:384–394CrossRefPubMed Mazziotti G, Biagioli E, Maffezzoni F, Spinello M, Serra V, Maroldi R, Floriani I, Giustina A (2015) Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis. J Clin Endocrinol Metab 100:384–394CrossRefPubMed
6.
Zurück zum Zitat Bonadonna S, Mazziotti G, Nuzzo M, Bianchi A, Fusco A, De Marinis L, Giustina A (2005) Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in post-menopausal women. J Bone Miner Res 20:1837–1844CrossRefPubMed Bonadonna S, Mazziotti G, Nuzzo M, Bianchi A, Fusco A, De Marinis L, Giustina A (2005) Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in post-menopausal women. J Bone Miner Res 20:1837–1844CrossRefPubMed
7.
Zurück zum Zitat Mazziotti G, Bianchi A, Bonadonna S, Cimino S, Patelli I, Fusco A, Pontecorvi A,, De Marinis L, Giustina A (2008) Prevalence of fractures in men with acromegaly. J Clin Endocrinol Metab 9:4649–4655CrossRef Mazziotti G, Bianchi A, Bonadonna S, Cimino S, Patelli I, Fusco A, Pontecorvi A,, De Marinis L, Giustina A (2008) Prevalence of fractures in men with acromegaly. J Clin Endocrinol Metab 9:4649–4655CrossRef
8.
Zurück zum Zitat Wassenaar MJ, Biermasz NR, Hamdy NA, Zillikens MC, Van Meurs JB, Rivadeneira F, Hofman A, Uitterlinden AG, Stokkel MP, Roelfsema F, Kloppenburg M, Kroon HM, Romijn JA, Pereira AM (2011) High prevalence of vertebral fractures despite normal bone mineral density in patients with long term controlled acromegaly. Eur J Endocrinol 164:475–483CrossRefPubMed Wassenaar MJ, Biermasz NR, Hamdy NA, Zillikens MC, Van Meurs JB, Rivadeneira F, Hofman A, Uitterlinden AG, Stokkel MP, Roelfsema F, Kloppenburg M, Kroon HM, Romijn JA, Pereira AM (2011) High prevalence of vertebral fractures despite normal bone mineral density in patients with long term controlled acromegaly. Eur J Endocrinol 164:475–483CrossRefPubMed
9.
Zurück zum Zitat Lim SV, Marenzana M, Hopkinson M, List EO, Kopchick JJ, Pereira M, Javaheri B, Roux JP, Chavassieux P, Korbonits M, Chenu C (2015) Excessive growth hormone expression in male GH transgenic mice adversely alters bone architecture and mechanical strength. Endocrinology 156:13562–13571 Lim SV, Marenzana M, Hopkinson M, List EO, Kopchick JJ, Pereira M, Javaheri B, Roux JP, Chavassieux P, Korbonits M, Chenu C (2015) Excessive growth hormone expression in male GH transgenic mice adversely alters bone architecture and mechanical strength. Endocrinology 156:13562–13571
10.
Zurück zum Zitat Riggs L, Randall RV, Wanner HW, Jowsey J, Kelly PJ, Singh M (1972) The nature of metabolic bone disorder in acromegaly. J Clin Endocrinol Metab 34:911–918CrossRefPubMed Riggs L, Randall RV, Wanner HW, Jowsey J, Kelly PJ, Singh M (1972) The nature of metabolic bone disorder in acromegaly. J Clin Endocrinol Metab 34:911–918CrossRefPubMed
11.
Zurück zum Zitat Halse J, Melsen F, Mosekilde L (1981) Iliac crest bone mass and remodelling in acromegaly. Acta Endocrinol 97:18–22PubMed Halse J, Melsen F, Mosekilde L (1981) Iliac crest bone mass and remodelling in acromegaly. Acta Endocrinol 97:18–22PubMed
12.
Zurück zum Zitat Ueland T, Ebbesen EN, Thomsen JS, Mosekilde L, Brixen K, Flyvbjerg A, Bollerslev J (2002) Decreased trabecular bone biomechanical competence, apparent density, IGF-II and IGFBP-5 content in acromegaly. Eur J Clin Invest 32:122–128CrossRefPubMed Ueland T, Ebbesen EN, Thomsen JS, Mosekilde L, Brixen K, Flyvbjerg A, Bollerslev J (2002) Decreased trabecular bone biomechanical competence, apparent density, IGF-II and IGFBP-5 content in acromegaly. Eur J Clin Invest 32:122–128CrossRefPubMed
13.
Zurück zum Zitat Madeira M, Neto LV, de Paula Paranhos Neto F, Barbosa Lima IC, Carvalho de Mendonça LM, Gadelha MR, Fleiuss de Farias ML (2013) Acromegaly has a negative influence on trabecular bone, but not on cortical bone, as assessed by high-resolution peripheral quantitative computed tomography. J Clin Endocrinol Metab 98(4):1734–1741CrossRefPubMed Madeira M, Neto LV, de Paula Paranhos Neto F, Barbosa Lima IC, Carvalho de Mendonça LM, Gadelha MR, Fleiuss de Farias ML (2013) Acromegaly has a negative influence on trabecular bone, but not on cortical bone, as assessed by high-resolution peripheral quantitative computed tomography. J Clin Endocrinol Metab 98(4):1734–1741CrossRefPubMed
14.
Zurück zum Zitat Hong AR et al (2016) Trabecular bone score as a skeletal fragility index in acromegaly patients. Osteoporos Int 27:1123–1129CrossRefPubMed Hong AR et al (2016) Trabecular bone score as a skeletal fragility index in acromegaly patients. Osteoporos Int 27:1123–1129CrossRefPubMed
15.
Zurück zum Zitat Godang K et al (2016) Treatment of acromegaly increases BMD but reduces trabecular bone score: a longitudinal study. Eur J Endocrinol 175:155–164CrossRefPubMed Godang K et al (2016) Treatment of acromegaly increases BMD but reduces trabecular bone score: a longitudinal study. Eur J Endocrinol 175:155–164CrossRefPubMed
16.
Zurück zum Zitat Malgo F et al (2017) Bone material strength index as measured by impact microindentation is low in patients with fractures irrespective of fracture site. Osteoporos Int 28:2433–2437CrossRefPubMedPubMedCentral Malgo F et al (2017) Bone material strength index as measured by impact microindentation is low in patients with fractures irrespective of fracture site. Osteoporos Int 28:2433–2437CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Maffezzoni F, Maddalo M, Frara S, Mezzone M, Zorza I, Baruffaldi F, Doglietto F, Mazziotti G, Maroldi R, Giustina A (2016) High-resolution-cone beam tomography analysis of bone microarchitecture in patients with acromegaly and radiological vertebral fractures. Endocrine 54:532–542CrossRefPubMed Maffezzoni F, Maddalo M, Frara S, Mezzone M, Zorza I, Baruffaldi F, Doglietto F, Mazziotti G, Maroldi R, Giustina A (2016) High-resolution-cone beam tomography analysis of bone microarchitecture in patients with acromegaly and radiological vertebral fractures. Endocrine 54:532–542CrossRefPubMed
18.
Zurück zum Zitat Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A, Wass JA, Endocrine Society (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99:3933–3951CrossRefPubMed Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A, Wass JA, Endocrine Society (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99:3933–3951CrossRefPubMed
19.
Zurück zum Zitat Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, Casanueva FF, Trainer P, Ghigo E, Ho K, Melmed S (2010) A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 95:3141–3148CrossRefPubMed Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, Casanueva FF, Trainer P, Ghigo E, Ho K, Melmed S (2010) A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 95:3141–3148CrossRefPubMed
20.
Zurück zum Zitat Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM, Endocrine Society (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96:1911–1930CrossRefPubMed Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM, Endocrine Society (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96:1911–1930CrossRefPubMed
21.
Zurück zum Zitat WHO Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. Geneva, World Health Organization, 1994 (WHO Technical Report Series, No. 843) WHO Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. Geneva, World Health Organization, 1994 (WHO Technical Report Series, No. 843)
22.
Zurück zum Zitat Genant HK, Jergas M, Palermo L, Nevitt M, Valentin RS, Black D, Cummings SR (1996) Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis The Study of Osteoporotic Fractures Research Group. J Bone Miner Res 11:984–996CrossRefPubMed Genant HK, Jergas M, Palermo L, Nevitt M, Valentin RS, Black D, Cummings SR (1996) Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis The Study of Osteoporotic Fractures Research Group. J Bone Miner Res 11:984–996CrossRefPubMed
23.
Zurück zum Zitat Dalle Carbonare L, Matte’ A, Valenti MT, Siciliano A, Mori A, Schweiger V, Zampieri G, Perbellini L, De Franceschi L (2015) Hypoxia-reperfusion affects osteogenic lineage and promotes sickle cell bone disease. Blood 126:2320–2328CrossRefPubMed Dalle Carbonare L, Matte’ A, Valenti MT, Siciliano A, Mori A, Schweiger V, Zampieri G, Perbellini L, De Franceschi L (2015) Hypoxia-reperfusion affects osteogenic lineage and promotes sickle cell bone disease. Blood 126:2320–2328CrossRefPubMed
24.
Zurück zum Zitat Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR, Parfitt AM (2013) Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 28:1–16CrossRef Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR, Parfitt AM (2013) Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 28:1–16CrossRef
25.
Zurück zum Zitat Ominsky MS, Boyd SK, Varela A, Jolette J, Felx M, Doyle N, Mellal N, Smith SY, Locher K, Buntich S, Pyrah I, Boyce RW (2017) Romosozumab improves bone mass and strength while maintaining bone quality in ovariectomized cynomolgus monkeys. J Bone Miner Res 32:788–801CrossRefPubMed Ominsky MS, Boyd SK, Varela A, Jolette J, Felx M, Doyle N, Mellal N, Smith SY, Locher K, Buntich S, Pyrah I, Boyce RW (2017) Romosozumab improves bone mass and strength while maintaining bone quality in ovariectomized cynomolgus monkeys. J Bone Miner Res 32:788–801CrossRefPubMed
26.
Zurück zum Zitat Dalle Carbonare L, Ballanti P, Bertoldo F, Valenti MT, Giovanazzi B, Giannini S, Realdi G, Lo Cascio V (2008) Trabecular bone microarchitecture in mild primary hyperparathyroidism. J Endocrinol Invest 31:525–530CrossRefPubMed Dalle Carbonare L, Ballanti P, Bertoldo F, Valenti MT, Giovanazzi B, Giannini S, Realdi G, Lo Cascio V (2008) Trabecular bone microarchitecture in mild primary hyperparathyroidism. J Endocrinol Invest 31:525–530CrossRefPubMed
27.
Zurück zum Zitat Courpron P, Meunier P, Bressot C, Giroux JM (1976) Amount of bone in the iliac crest biopsy. In: Meunier PJ (ed) Second international workshop on bone morphometry. Societe de la Nouvelle Imprimerie Fournie Toulouse, Lyon, pp 39–53 Courpron P, Meunier P, Bressot C, Giroux JM (1976) Amount of bone in the iliac crest biopsy. In: Meunier PJ (ed) Second international workshop on bone morphometry. Societe de la Nouvelle Imprimerie Fournie Toulouse, Lyon, pp 39–53
28.
Zurück zum Zitat Meunier PJ, Edouard C, Richard D, Laurent J (1976) Histomorphometry of osteoid tissue. The hyperosteoidoses. In: Meunier PJ (ed) Second international workshop on bone morphometry. Societe de la Nouvelle Imprimerie Fournie Toulouse, Lyon, pp 249–262 Meunier PJ, Edouard C, Richard D, Laurent J (1976) Histomorphometry of osteoid tissue. The hyperosteoidoses. In: Meunier PJ (ed) Second international workshop on bone morphometry. Societe de la Nouvelle Imprimerie Fournie Toulouse, Lyon, pp 249–262
29.
Zurück zum Zitat Meunier P, Edouard C, Courpron P (1976) Morphometric analysis of trabecular resorption surfaces in normal iliac bone. In: Jaworski ZFG (ed) Proceedings of the first workshop on bone morphometry. University of Ottowa Press, Ottawa, pp 156–160 Meunier P, Edouard C, Courpron P (1976) Morphometric analysis of trabecular resorption surfaces in normal iliac bone. In: Jaworski ZFG (ed) Proceedings of the first workshop on bone morphometry. University of Ottowa Press, Ottawa, pp 156–160
30.
Zurück zum Zitat Melsen F, Mosekilde L (1978) Tetracyline double-labeling of iliac trabecular bone in 41 normal adults. Calcif Tissue Res 26:99CrossRefPubMed Melsen F, Mosekilde L (1978) Tetracyline double-labeling of iliac trabecular bone in 41 normal adults. Calcif Tissue Res 26:99CrossRefPubMed
31.
Zurück zum Zitat Melsen F, Melsen B, Mosekilde L, Bergmann S (1978) Histomorphometric analysis of normal bone from the iliac crest. Acta Pathol Microbiol Scand A 86:70–81PubMed Melsen F, Melsen B, Mosekilde L, Bergmann S (1978) Histomorphometric analysis of normal bone from the iliac crest. Acta Pathol Microbiol Scand A 86:70–81PubMed
32.
Zurück zum Zitat Mazziotti G, Bianchi A, Porcelli T, Mormando M, Maffezzoni F, Cristiano A, Giampietro A, De Marinis L, Giustina A (2013) Vertebral fractures in patients with acromegaly: a 3-year prospective study. J Clin Endocrinol Metab 98:3402–3410CrossRefPubMed Mazziotti G, Bianchi A, Porcelli T, Mormando M, Maffezzoni F, Cristiano A, Giampietro A, De Marinis L, Giustina A (2013) Vertebral fractures in patients with acromegaly: a 3-year prospective study. J Clin Endocrinol Metab 98:3402–3410CrossRefPubMed
33.
Zurück zum Zitat Claessen KM, Kroon HM, Pereira AM, Appelman-Dijkstra NM, Verstegen ,M.J., Kloppenburg M, Hamdy NA, Biermasz NR (2013) Progression of vertebral fractures despite long-term biochemical control of acromegaly: a prospective follow-up study. J Clin Endocrinol Metab 98:4808–4815CrossRefPubMed Claessen KM, Kroon HM, Pereira AM, Appelman-Dijkstra NM, Verstegen ,M.J., Kloppenburg M, Hamdy NA, Biermasz NR (2013) Progression of vertebral fractures despite long-term biochemical control of acromegaly: a prospective follow-up study. J Clin Endocrinol Metab 98:4808–4815CrossRefPubMed
34.
Zurück zum Zitat Kurland ES, Rosen CJ, Cosman F, McMahon D, Chan F, Shane E, Lindsay R, Dempster D, Bilezikian JP (1997) Insulin-like growth factor-I in men with idiopathic osteoporosis. J Clin Endocrinol Metab 82:2799–2805PubMed Kurland ES, Rosen CJ, Cosman F, McMahon D, Chan F, Shane E, Lindsay R, Dempster D, Bilezikian JP (1997) Insulin-like growth factor-I in men with idiopathic osteoporosis. J Clin Endocrinol Metab 82:2799–2805PubMed
35.
Zurück zum Zitat Mazziotti G, Marzullo P, Doga M, Aimaretti G, Giustina A (2015) Growth hormone deficiency in treated acromegaly. Trends Endocrinol Metab 26:11–21CrossRefPubMed Mazziotti G, Marzullo P, Doga M, Aimaretti G, Giustina A (2015) Growth hormone deficiency in treated acromegaly. Trends Endocrinol Metab 26:11–21CrossRefPubMed
36.
Zurück zum Zitat Dutta P, Mahendran B, Reddy KS, Ahluwalia J, Vaiphei K, Kochhar RK, Gupta P, Srinivasan A, Prakash M, Mukherjee KK, Shah VN, Parthan G, Bhansali A (2015) Short-term efficacy of recombinant human GH therapy in cured acromegaly patients with GH deficiency: a single-center experience. Endocr Connect 4:65–75CrossRefPubMedPubMedCentral Dutta P, Mahendran B, Reddy KS, Ahluwalia J, Vaiphei K, Kochhar RK, Gupta P, Srinivasan A, Prakash M, Mukherjee KK, Shah VN, Parthan G, Bhansali A (2015) Short-term efficacy of recombinant human GH therapy in cured acromegaly patients with GH deficiency: a single-center experience. Endocr Connect 4:65–75CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Van der Klaauw AA, Bax JJ, Roelfsema F, Stokkel MP, Bleeker GB, Biermasz NR, Smit JW, Romijn JA, Pereira AM (2009) Limited effects of growth hormone replacement in patients with GH deficiency during long-term cure of acromegaly. Pituitary 12, 339–346CrossRefPubMedPubMedCentral Van der Klaauw AA, Bax JJ, Roelfsema F, Stokkel MP, Bleeker GB, Biermasz NR, Smit JW, Romijn JA, Pereira AM (2009) Limited effects of growth hormone replacement in patients with GH deficiency during long-term cure of acromegaly. Pituitary 12, 339–346CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Altinova AE, Ozkan C, Akturk M, Gulbahar O, Yalcin M, Cakir N, Toruner FB (2016) Vitamin D-binding protein and free vitamin D concentrations in acromegaly. Endocrine 52:374–379CrossRefPubMed Altinova AE, Ozkan C, Akturk M, Gulbahar O, Yalcin M, Cakir N, Toruner FB (2016) Vitamin D-binding protein and free vitamin D concentrations in acromegaly. Endocrine 52:374–379CrossRefPubMed
39.
Zurück zum Zitat Ajmal A, Haghshenas A, Attarian S, Barake M, Tritos NA, Klibanski A, Miller KK, Nachtigall LB (2014) The effect of somatostatin analogs on vitamin D and calcium concentrations in patients with acromegaly. Pituitary 17:366–373CrossRefPubMed Ajmal A, Haghshenas A, Attarian S, Barake M, Tritos NA, Klibanski A, Miller KK, Nachtigall LB (2014) The effect of somatostatin analogs on vitamin D and calcium concentrations in patients with acromegaly. Pituitary 17:366–373CrossRefPubMed
40.
Zurück zum Zitat Mazziotti G, Maffezzoni F, Frara S, Giustina A (2017) Acromegalic osteopathy. Pituitary 20:63–69CrossRefPubMed Mazziotti G, Maffezzoni F, Frara S, Giustina A (2017) Acromegalic osteopathy. Pituitary 20:63–69CrossRefPubMed
41.
Zurück zum Zitat Ezzat S, Melmed S, Endres D, Eyre DR, Singer FR (1993) Biochemical assessment of bone formation and resorption in acromegaly. J Clin Endocrinol Metab 76:1452–1457PubMed Ezzat S, Melmed S, Endres D, Eyre DR, Singer FR (1993) Biochemical assessment of bone formation and resorption in acromegaly. J Clin Endocrinol Metab 76:1452–1457PubMed
Metadaten
Titel
Bone histomorphometry in acromegaly patients with fragility vertebral fractures
verfasst von
L. Dalle Carbonare
V. Micheletti
E. Cosaro
M. T. Valenti
M. Mottes
G. Francia
M. V. Davì
Publikationsdatum
06.12.2017
Verlag
Springer US
Erschienen in
Pituitary / Ausgabe 1/2018
Print ISSN: 1386-341X
Elektronische ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-017-0847-1

Weitere Artikel der Ausgabe 1/2018

Pituitary 1/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.